Welcome to SynapCell
SynapCell is a biotechnology company providing the CNS drug manufacturing industry with translational drug discovery solutions to reveal the therapeutic potential of their molecules targeting CNS disorders.
Feedback on Eilat XII from the CEO of SynapCell
August 31 – September 3, 2014
I am just back from Madrid (Spain) where I attended Eilat XII, the conference on anti-epileptic drugs (AEDs). I believe the conference was a success, it brought together people from biotech and pharma industries, clinicians and academics to discuss epilepsy and AEDs, whether already on the market or under development.
The meeting began with an active discussion of the different topics related to pharmacoresistance, which is still a subject of debate. No consensus was reached as both sides of the argument were supported by clinical, academic and industrial experience!